Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 407.9B | 391.0B | 423.4B |
Cost of revenue | — | 245.1B | 229.1B | 258.3B |
Gross profit | — | 162.8B | 162.0B | 165.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 101.4B | 101.2B | 103.6B |
Operating income | 38.8B | 32.4B | 31.7B | 33.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 21.2B | 21.3B | 20.7B |
Other income expense | — | — | — | — |
Pretax income | — | 11.8B | 7.9B | 13.8B |
Tax provision | — | 4.6B | 3.9B | 5.1B |
Net income | — | 7.2B | 4.0B | 8.7B |
Basic EPS | — | 2.9 | 1.8 | 3.5 |
Diluted EPS | — | 2.9 | 1.8 | 3.5 |
Basic average shares | — | 2.4B | 2.4B | 2.4B |
Diluted average shares | — | 2.4B | 2.4B | 2.4B |
EBITDA | — | 57.3B | 55.3B | 56.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -20M | 350M | -220M |
Preferred stock dividends | 0 | 0 | 0 | 0 |